References
- Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, Beerli P, Su XZ. Early origin and recent expansion of Plasmodium falciparum. Science 2003;300:318–321.
- Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455–467.
- Surolia A, Ramya TN, Ramya V, Surolia N. ‘FAS’t inhibition of malaria. Biochem J 2004;383:401–412.
- Agarwal A, Kumkum Srivastava, Puri SK, Prem MSC. Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents. Bioorg Med Chem 2005;13:6226–6232.
- Rollas S, Küçükgüzel SG. Biological activities of hydrazone derivatives. Molecules 2007; 12:1910–1939.
- Prachayasittikul S, Treeratanapiboon L, Ruchirawat S, Prachayasittikul V. Novel activities of 1-adamantylthiopyridines as antibacterials, antimalarials and anticancers. EXCLI J 2009;8:121–129.
- Pingaew R, Prachayasittikul S, Ruchirawat S. Synthesis, cytotoxic and antimalarial activities of benzoyl thiosemicarbazone analogs of isoquinoline and related compounds. Molecules 2010; 15:988–996.
- Rodrigues T, Guedes RC, dos Santos DJ, Carrasco M, Gut J, Rosenthal PJ, Moreira R, Lopes F. Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials. Bioorg Med Chem Lett 2009; 19:3476–3480.
- Phillips MA, Rathod PK. Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy. Infect Disord Drug Targets 2010; 10:226–239.
- Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg 1993; 48:205–210.
- Peters W, Robinson BL. (1999) Parasitic infection models: Handbook of animal models of infection. London: Academic Press, 757–773.
- Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976;193:673–675.
- Loiseaul PM, Xuong ND. Plasmodium berghei mouse model: Antimalarial activity of new alkaloid salts and of thiosemicarbazone and acridine derivatives. Trop Med and Inter Health 1996;1:379–384.
- Kiseko K, Hiroyuki M, Syun-ichi F, Ryuiichi F, Tomotaka K, Seiji M. Anti-malarial activity of leaf-extract of Hydrangea macrophyla, a common Japanese plant. Acta Med Okayama 2000;54:227–232.
- Kalra BS, Chawla S, Gupta P, Valecha N. Screening of antimalarial drug. Ind J Pharmacol 2006;38:1–12.
- Cravo P, Culleton R, Hunt P, Walliker D, Mackinnon MJ. Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrob Agents Chemother 2001; 45:2897–2901.
- Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979; 65:418–420.
- Verma M, Tripathi M, Saxena AK, Shanker K. Antiinflammatory activity of novel indole dervatives. Eur J Med Chem 1994;29:941–946.
- Bekhit AA, Fahmy HTY. Design and synthesis of some substituted 1H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents. Arch Pharm Pharm Med Chem 2003; 336:111–118.
- Molecular Operating Environment (MOE). Version 2005–06. Chemical Computing Group, Inc: Montreal, Canada. Available at: http://www.chemcomp.com
- Bekhit AA, Baraka AM. Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents. Eur J Med Chem 2005;40:1405–1413.
- Domling A. Isocyanide based multi component reactions in combinatorial chemistry. High Throughput Screen 1998;1:1–22.